Scarica l'app Stockscreener
57.63
0.35%
0.20
Tarsus Pharmaceuticals Inc Azioni (TARS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
31.05%
102.66
|
78.33 | 66.41 | 48.12 | 40.81 |
Operating Expenses
|
19.34%
124.84
|
104.61 | 90.83 | 73.28 | 74.11 |
| Benefits Costs and Expenses |
19.34%
124.84
|
104.61 | 85.81 | 73.28 | 74.11 |
| Costs And Expenses |
19.34%
124.84
|
104.61 | 90.83 | 73.28 | 74.11 |
| Operating Income/Loss |
15.59%
-22.18
|
-26.28 | -24.42 | -25.16 | -33.30 |
| Nonoperating Income/Loss |
58.97%
1.844
|
1.16 | 1.308 | 1.742 | 0.012 |
| Income/Loss From Continuing Operations Before Tax |
11.69%
-22.18
|
-25.12 | -19.41 | -25.16 | -33.29 |
| Income/Loss From Continuing Operations After Tax |
19.03%
-20.34
|
-25.12 | -23.11 | -23.42 | -33.29 |
|
Net Income/Loss
|
19.03%
-20.34
|
-25.12 | -23.11 | -23.42 | -33.29 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
7.66%
42.36
|
39.35 | 0.3176 | 38.38 | 37.82 |
| Diluted Average Shares |
7.66%
42.36
|
39.35 | 0.3176 | 38.38 | 37.82 |
| Basic Earnings Per Share |
25.00%
-0.48
|
-0.64 | -0.59 | -0.61 | -0.88 |
| Diluted Earnings Per Share |
25.00%
-0.48
|
-0.64 | -0.59 | -0.61 | -0.88 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):